The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 20, 2015
Filed:
Jul. 03, 2012
Applicants:
Craig Boyle, Branchburg, NJ (US);
William Greenlee, Teaneck, NJ (US);
Samuel Chackalamannil, Califon, NJ (US);
Claire Lankin, High Bridge, NJ (US);
Inventors:
Craig Boyle, Branchburg, NJ (US);
William Greenlee, Teaneck, NJ (US);
Samuel Chackalamannil, Califon, NJ (US);
Claire Lankin, High Bridge, NJ (US);
Assignee:
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 261/20 (2006.01); A61K 31/423 (2006.01); A61K 31/167 (2006.01); C07D 215/38 (2006.01); C07D 217/22 (2006.01); C07D 401/12 (2006.01); C07D 239/42 (2006.01); C07D 295/192 (2006.01); C07C 257/18 (2006.01); C07C 235/38 (2006.01); A61K 31/47 (2006.01); A61K 31/472 (2006.01); A61K 31/505 (2006.01); A61K 31/506 (2006.01); A61K 31/5375 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); C07C 235/16 (2006.01);
U.S. Cl.
CPC ...
A61K 31/167 (2013.01); A61K 31/423 (2013.01); A61K 31/47 (2013.01); A61K 31/472 (2013.01); A61K 31/505 (2013.01); A61K 31/506 (2013.01); A61K 31/5375 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07C 235/16 (2013.01); C07C 235/38 (2013.01); C07C 257/18 (2013.01); C07D 215/38 (2013.01); C07D 217/22 (2013.01); C07D 239/42 (2013.01); C07D 261/20 (2013.01); C07D 295/192 (2013.01); C07D 401/12 (2013.01);
Abstract
The present invention provides a compound of Formula (I) as described herein, or a pharmaceutically acceptable salt thereof. The present invention also provides pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.